Shanghai Rightongene Biotechnology Co., Ltd. (SHA:688217)
China · Delayed Price · Currency is CNY 26.54
-0.16 (-0.60%)
At close: Jul 15, 2025, 2:57 PM CST
SHA:688217 Market Cap
SHA:688217 has a market cap or net worth of 1.50 billion as of July 17, 2025. Its market cap has increased by 28.43% in one year.
Market Cap
1.50B
Enterprise Value
1.29B
Revenue
232.86M
Ranking
n/a
PE Ratio
n/a
Stock Price
26.54
Market Cap Chart
Since May 17, 2021, SHA:688217's market cap has decreased from 5.91B to 1.50B, a decrease of -74.64%. That is a compound annual growth rate of -28.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 17, 2025 | 1.50B | 47.40% |
| Dec 31, 2024 | 1.02B | -49.08% |
| Dec 29, 2023 | 2.00B | 1.72% |
| Dec 30, 2022 | 1.96B | -51.39% |
| Dec 31, 2021 | 4.04B | -31.67% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 381.37B |
| Shenzhen Mindray Bio-Medical Electronics | 262.66B |
| WuXi AppTec | 225.41B |
| Zhangzhou Pientzehuang Pharmaceutical., | 119.06B |
| Sichuan Biokin Pharmaceutical | 117.85B |
| Aier Eye Hospital Group | 114.24B |
| Shanghai United Imaging Healthcare | 102.75B |
| Yunnan Baiyao Group Co.,Ltd | 99.76B |